Validation Study of the EMILY AI Device in Acute and Chronic Respiratory Failure
Recruiting
N/A
Interventional Study
Chronic Respiratory Failure
Acute Respiratory Failure
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 20 (estimated)
- Sponsor
- Aether Tech S.L. · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Currently, there is no holistic solution for patients with respiratory diseases that includes oxygenation and management of a patient with respiratory disease, combining dynamic and automatic O2 administration and the detection of clinical worsening, generating a diagnostic suspicion, a management proposal, and notifying the medical team.
For device validation, prospective studies will be conduct…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Men and women over 18 years of age.
* Admitted to intermediate respiratory care unit with a diagnosis of acute respiratory failure for at least 8 hours.
* Informed consent understood and signed.
Exclusion Criteria:
* Hemodynamic instability.
* Severe temperature changes.
* H…
Contacts
No contact information available.